Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/MGX/Total assets

Metagenomi Therapeutics, Inc. (MGX) Total assets 2023–2025

Metagenomi Therapeutics, Inc. (MGX) total assets at each fiscal year-end, per SEC filings.

$221.1MFY2025 · since FY2023: $364.8M → $221.1M
232425
Fiscal yearValueYoY
FY2025$221.1M-31.9%
FY2024$324.6M-11.0%
FY2023$364.8M—

Source: SEC XBRL filings · For reference only · Not investment advice

More MGX financial trends

MGX RevenueMGX Net incomeMGX Net marginMGX Gross profitMGX Gross marginMGX Operating incomeMGX Operating marginMGX Operating cash flowMGX Free cash flowMGX Capital expendituresMGX Return on equityMGX Stock buybacksMGX Dividends paidMGX Total liabilitiesMGX Shareholders’ equityMGX overview →